Rebecca Andrews | Oct 13, 1991 | 8 min read
New Technologies Improve Biotech's Downstream Processing Author: Rebecca Andrews, p. 24, 25. Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As biotechnology companies seek regulatory approval for their products, however, they also face the problem of producing these proteins in quantity, at an affordable cost. Downstream processing is the isolation and